Sphere

Sphere EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Sphere (347700.KQ) as of Oct 20, 2026 is 222.44. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -152.65 — a change of -245.72% (higher).

EV/EBITDA

222.44

YoY

-245.72%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Sphere is 2025 222.44 . EV/EBITDA (Enterprise Value to EBITDA) of Sphere was 2024 -152.65 . It decreases by -245.72% higher compared to the previous year.

The Sphere EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
-716.06 KRW
Jan 1, 2019
-612.00 KRW
Jan 1, 2020
-719.47 KRW
Jan 1, 2021
-404.21 KRW
Jan 1, 2022
-449.06 KRW
Jan 1, 2023
-251.97 KRW
Jan 1, 2024
-152.65 KRW
Jan 1, 2025
222.44 KRW
The Sphere EV/EBITDA history
YEAREV/EBITDAYoY
222.44-245.72%
-152.65-39.42%
-251.97-43.89%
-449.06+11.10%
-404.21-43.82%
-719.47+17.56%
-612.00-14.53%
-716.06-185.51%
837.42—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sphere Stock analysis

What does Sphere do? Sphere Corp, listed under the ticker 347700.KQ and ISIN KR7347700007, is a South Korean health care company headquartered in Seoul. The company went public on March 23, 2021, and currently employs 53 full-time staff. Sphere Corp operates within the health care sector, focusing on digital health technology platforms and solutions. The company's website is https://lifesemantics.kr/, which serves as its primary online presence. Sphere Corp provides a digital health record data platform, enabling personalized health management through technology. The company's offerings include digital health technology platforms and digital health solutions, though specific product names such as LifeRecord, H.AI, OHA, Dr. Call, Redpill care, and Redpill breathtaking are not verified as part of the company's official portfolio. Additionally, Sphere Corp engages in the sale of diagnostic reagents and equipment, though details regarding these products are not elaborated in the provided information. The company's operations are based in Seoul, South Korea, and it is categorized under the health care industry. The information regarding its founding year, key personnel, and specific financial figures is not included in the provided data. Sphere Corp's focus remains on delivering digital health services through its platform, aiming to enhance personalized health care experiences for users. Sphere is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sphere stock

EV/EBITDA (Enterprise Value to EBITDA) of Sphere is 222.44 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Sphere changed from -152.65 to 222.44, representing a -245.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Sphere since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Sphere with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Sphere

All Key Metrics — Sphere